RESULTS & DISCUSSION
• WHOLE-GENE / . E6 did not differ significantly from neutrality ( ≈ ). All other genes were under purifying selection ( < ), but this was significantly relaxed in E7 for controls ( Table 1) . 13 • SLIDING WINDOWS FOR NONSYNONYMOUS PEAK DISCOVERY. Fourteen (14) nine-codon peaks were identified in which exceeded of both the peak and the gene. These were concatenated, endtrimmed, and considered candidate epitopes ( Table 1; Fig. 2 ).
• BENCHMARKING PEAKS AS CANDIDATE EPITOPES. Prior in vivo work shows peak E6#1 overlaps an HLA-B7 epitope and a p53 degrading region. 14,15 E6#2 overlaps L90[83]V (T350G), implicated in differential cancer risk; HLA-B44, -B51, and -B57 epitopes; and antibody epitopes (Fig. 2) . 16, 17 Moreover, 9/14 candidates matched in vitro or in vivo verified epitopes in online databases (Table 1) .
• CANDIDATE EPITOPES OVERLAP LINEAGE-DEFINING SITES. When controlling for lineage signal by limiting analyses to A1, peaks nevertheless overlap 37/360 lineage defining sites in coding regions, representing significant enrichment compared to random peak placement (11.34 ± 0.12 S.E. expected; permutation test; Z=210; P≈0). Excluding E2#1 (longest) did not change this conclusion.
• CONCLUSIONS AND IMPLICATIONS. Ongoing immune selection may have played a role in the historical divergence of the HPV16 sublineages. Population genetic detection of natural selection may allow rapid epitope characterization from sequence data alone.
• FUTURE DIRECTION. Include other sublineages; bootstrap peak / ; manufacture candidate epitopes to assay MHC binding. 
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METHODS
We used a custom Ion Torrent sequencing method 7 to obtain whole HPV16 viral genomes from 3,215 HPV-positive specimens from women undergoing cervical cancer screening at Kaiser Permanente Northern California in the Persistence and Progression (PaP) cohort. 4 From these, we identified 795 sublineage A1 cases and 839 A1 controls. Aligned sequences were analyzed with SNPGenie 8 to estimate and for all viral codons using a Nei-Gojobori approach. 9,10 Sliding windows of 9 codons (step size of 1) were performed to reflect T-cell epitope size. 6 Z-test bootstraps and permutation tests were performed with 1000 replicates. Candidate epitopes were queried as all contiguous octamers at Immune Epitope Database (IEDB) 11 and HPV T-Cell Antigen Database. 12 Results were analyzed and visualized in Excel, R version 3.4.0, Perl, and PowerPoint.
INTRODUCTION
Human papillomaviruses (HPVs) are highly prevalent (~40%) 1 in adults. Most of the >200 HPV types are benign. Cervical cancer is caused by~12 high-risk HPV types, 2 with >50% caused by HPV type 16 (HPV16) alone. The genetic basis of HPV16's unique carcinogenicity is unsolved. HPV16 consists of~13 sublineages across 4 lineages (A: A1-4; B: B1-2; C: C1-3; and D: D1-4) which exhibit >100x cancer risk differences. 3,4 HPV16 sublineages contain lineage defining variants (i.e., diagnostic characters) 4 in their genomes of~8kb circular dsDNA comprised of 8 genes (Fig. 1) .
Between-host mean viral nonsynonymous (N; amino acidaltering) and synonymous (S; amino acid-conserving) nucleotide distances can be measured as and . Regions under diversifying positive selection may exhibit > . 5 One target of selection is immune epitopes, viral peptide fragments identified by antibodies or T-cells. 6 Individuals differ in their ability to detect epitopes based on immune alleles, allowing inter-host selection. Figure 1 Phylogenetic tree of HPV16 sublineages, adapted from Mirabello et al. 4 Lineagedefining variants (diagnostic characters) are shown (|) along the genome, cumulative toward terminal nodes (e.g., all A variants are present in A1-4). The HPV16 genome contains oncogenes E6 and E7; early genes E1, E2, E4, and E5; late genes L1 and L2; and a URR. 
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Figure 2 Nucleotide distance 9-codon sliding window results for portions of E6 and E5. Nonsynonymous peak numbers (#i) and details are as described in Methods and 
